Wednesday, October 7, 2026

ID Logistics Trades at 4x DCF Value: €354 Stock Price vs €87 Intrinsic Value

ID Logistics Group shares trade at €354 on Euronext Paris — 4.06 times the DCF intrinsic value of €87.24. A reversion to fundamental pricing implies more than 75% downside. Analyst consensus at €482.57 diverges sharply from the DCF model, creating an unusually wide range of plausible outcomes.

LM Salvado
LM Salvado

May 19, 2026

ID Logistics Trades at 4x DCF Value: €354 Stock Price vs €87 Intrinsic Value
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

ID Logistics Group trades at significant capitalon Euronext Paris — 4.06 times its DCF intrinsic value of significant capital.1 A shift toward fundamental pricing would imply more than 75% downside from current levels.1

The French mid-cap operates across warehousing, e-commerce fulfillment, and supply chain outsourcing. Shares have extended well beyond what discounted cash flow models support, creating a valuation gap that fundamental analysis flags as extreme.

DCF modeling places intrinsic value at significant capital.1 At significant capitalinvestors are paying a 4x premium over that figure. Growing into this valuation would require sustained earnings expansion well beyond what the DCF framework currently incorporates.

Analyst consensus sits at significant capital— above the current trading price and pointing in the opposite direction from the DCF estimate.1 The divergence suggests sell-side forecasts may be embedding aggressive growth assumptions that discounted cash flow mechanics do not validate. When consensus and DCF point in opposite directions, the spread between them defines the range of plausible outcomes.

For traders, the setup is asymmetric.A reversion to the DCF intrinsic value implies more than 75% downside.1 Direction depends entirely on which framework the market chooses to anchor on.

ID Logistics operates in sectors with genuine growth potential: third-party logistics, warehouse automation, and e-commerce supply chain outsourcing are all expanding. Sector momentum alone rarely sustains a 4x premium over intrinsic value indefinitely. The question is timing, not direction.

Repricing risk is medium-likelihood — a structural vulnerability rather than an imminent collapse. Catalysts that could accelerate reversion include earnings misses, a rotation out of growth equities, or rising discount rates compressing DCF outputs across the logistics sector.

Short-side traders may find the risk-reward compelling. Long investors should stress-test growth assumptions against the DCF floor before adding to positions at current levels.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com